Abstract

In the United States (US), drug shortages have been a particularly prevalent issue, especially concerning generic drugs and biologics. These shortages affect treatments for a wide range of diseases, from mild to moderate conditions to severe life-threatening illnesses. The scarcity of oncology-related drugs is particularly concerning, as these medications play a crucial role in cancer treatment and have a direct impact on human lives. In this article, we will discuss two such drugs, Cisplatin and carboplatin, examining their causes of the current shortage and exploring potential solutions that could help alleviate these drug shortages.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call